title: Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.
abstract: Endocrine functions were investigated in a case of "beta-adrenergic hyperdynamic circulatory state". This state was diagnosed by (1) typical symptoms of cardiac awareness, (2) physical findings (increments of pulse rate and blood pressure by changing positions or walking), (3) increase in cardiac output (5.25 l/min leads to 14.03 l/min) and decrease in circulatory time (10.8 sec leads to 5.5 sec) by isoproterenol infusion (0.02 mug/min/kg body weight), (4) rapid loss of symptoms and above findings by propranolol treatment (30 mg per os daily) and reappearance by discontinuing medication. The mechanism of insulin response to glucose has been a controversy as to whether the secretion is transmitted by beta-receptor or independent glucose receptor. And in this physiologic beta-adrenergic state, it was found that insulin responses in IVGTT and OGTT were within normal limit. When beta-adrenergic condition was corrected by propranolol treatment, insulin responses were shown lowered, though in the normal range. This could be reproduced by discontinuing medication. Insulin, glucagon and growth hormone secretions caused by arginine were also found normal, but during the period the patient was on propranolol therapy, all responses were decreased, within the normal range. These results do not positively support the idea that glucose receptor is linked to beta-receptor. They do not either agree with the contention that secretions of insulin, glucagon and growth hormone induced by arginine are mediated through beta-receptors.
mesh_terms: D001120:Arginine / Q000494:pharmacology; D001786:Blood Glucose; D000242:Cyclic AMP / Q000652:urine; D005260:Female; D005934:Glucagon / Q000097:blood*; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006973:Hypertension / Q000097:blood; D007328:Insulin / Q000097:blood*; D008333:Mandelic Acids / Q000652:urine; D008676:Metanephrine / Q000652:urine; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D013577:Syndrome; D014652:Vascular Diseases / Q000097:blood* / Q000188:drug therapy / Q000652:urine
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008333:Mandelic Acids; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D008676:Metanephrine; D013006:Growth Hormone; D005934:Glucagon; D001120:Arginine; D011433:Propranolol; D000242:Cyclic AMP